EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light

Izabela K Ragan, Lindsay M Hartson iD, Elizabeth J Sullivan, Richard A Bowen, Raymond P Goodrich iD

PLOS ONE · 20.01.2023 · 18 (1) · e0278862

DOI: 10.1371/journal.pone.0278862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.01.2023. Verfasst von Izabela K Ragan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Monkeypox virus, Viremia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DOD Peer Reviewed Medical Research Program, Colorado State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monkeypox virus has recently emerged from endemic foci in Africa and, since October 20, 2022, more than 73,000 human infections have been reported by the CDC from over 100 countries that historically have not reported monkeypox cases. The detection of virus in skin lesions, blood, semen, and saliva of infected patients with monkeypox infections raises the potential for disease transmission via routes that have not been previously documented, including by blood and plasma transfusions. Methods for protecting the blood supply against the threats of newly emerging disease agents exist and include Pathogen Reduction Technologies (PRT) which utilize photochemical treatment processes to inactivate pathogens in blood while preserving the integrity of plasma and cellular components. Such methods have been employed broadly for over 15 years, but effectiveness of these methods under routine use conditions against monkeypox virus has not been reported. Study design and methods Monkeypox virus (strain USA_2003) was used to inoculate plasma and whole blood units that were then treated with riboflavin and UV light (Mirasol Pathogen Reduction Technology System, Terumo BCT, Lakewood, CO). The infectious titers of monkeypox virus in the samples before and after riboflavin + UV treatment were determined by plaque assay on Vero cells.

Results

The levels of spiked virus present in whole blood and plasma samples exceeded 10 3 infectious particles per dose, corresponding to greater than 10 5 DNA copies per mL. Treatment of whole blood and plasma units under standard operating procedures for the Mirasol PRT System resulted in complete inactivation of infectivity to the limits of detection. This is equivalent to a reduction of ≥ 2.86 +/- 0.73 log 10 pfu/mL of infectivity in whole blood and ≥ 3.47 +/-0.19 log 10 pfu/mL of infectivity in plasma under standard operating conditions for those products.

Conclusion

Based on this data and corresponding studies on infectivity in patients with monkeypox infections, use of Mirasol PRT would be expected to significantly reduce the risk of transfusion transmission of monkeypox.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mpox, MonkeypoxMonkeypox virusViremiaAnimalsHumansBlood PlateletsChlorocebus aethiopsRiboflavinUltraviolet RaysVero Cells

Substanzen

Riboflavin

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
  • Infectious Disease Research Center, Colorado State University, Fort Collins, Colorado, United States of America.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.

ORCID-Profile: Lindsay M Hartson, Raymond P Goodrich

Förderung

  • DOD Peer Reviewed Medical Research Program
  • Colorado State University

Zitieren

APA

Ragan, I. K., Hartson, L. M., Sullivan, E. J., Bowen, R. A., & Goodrich, R. P. (2023). Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light. PLOS ONE, 18(1), e0278862. https://doi.org/10.1371/journal.pone.0278862

Vancouver

Ragan IK, Hartson LM, Sullivan EJ, Bowen RA, Goodrich RP. Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light. PLOS ONE. 2023;18(1):e0278862. doi:10.1371/journal.pone.0278862

BibTeX
@article{Ragan2023,
  author = {Ragan, Izabela K and Hartson, Lindsay M and Sullivan, Elizabeth J and Bowen, Richard A and Goodrich, Raymond P},
  title = {Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {1},
  pages = {e0278862},
  doi = {10.1371/journal.pone.0278862}
}
Kostenlos starten →